DocDollars

Ferring Pharmaceuticals Inc.

NJ · United States · Reporting entity ID 100000000309

Total reported 2019–2025
$14.0M
#407 of 2,960 reporting companies — 0% of all reported industry payments
$12.2M in general payments across 134,163 records, plus $1.83M in research funding across 89 records.

How it breaks down

General payments $12,169,396
Research funding $1,825,643

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.

Summary

Ferring Pharmaceuticals Inc. reported $14.0M to US doctors and teaching hospitals from 2019 to 2025, ranking #407 of 2,960 reporting companies. 13% of that was research funding and 87% general payments such as consulting, speaking, food and travel. 134,163 general payment records and 89 research records were filed.

Common questions about Ferring Pharmaceuticals Inc.

How much has Ferring Pharmaceuticals Inc. paid US doctors?

Ferring Pharmaceuticals Inc. reported $13,995,038 to US physicians and teaching hospitals across the 2019–2025 Open Payments program years: $12,169,396 in general payments, $1,825,643 in research funding.

How does Ferring Pharmaceuticals Inc. rank among drug and device companies?

It ranks #407 of 2,960 reporting entities by total reported value, about 0% of all industry payments in the dataset.

Does a payment from Ferring Pharmaceuticals Inc. mean a doctor did something wrong?

No. Open Payments records transfers of value such as speaking fees, consulting, meals, travel and research funding. The data shows the relationship, not its effect on prescribing or care.